Project Number 1U01NS074501-01 Agency/Funding Organization NINDS Funding Year 2011 View Full Project Details for OPTIMIZATION OF SOLUBLE GAMMA-SECRETASE MODULATORS FOR THE TREATMENT OF ALZHEIMER Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 4. Non-clinical Drug Development (small molecules and biologics) a. Amyloid beta Researcher and Organization Principal Investigator WAGNER, STEVEN LEE Principal Investigator First Name WAGNER Principal Investigator Last Name STEVEN LEE Awardee Organization UNIVERSITY OF CALIFORNIA SAN DIEGO Awardee State California Contact PI Country United States Project Detail Funding Opportunity Announcement RFA-NS-11-002: NIH BLUEPRINT FOR NEUROSCIENCE RESEARCH GRAND CHALLENGE: DEVELOPING NOVEL DRUGS FOR DISORDERS OF THE NERVOUS SYSTEM (U01) FY Overall Cost $245,040 Funding Organization Agency/Funding Organization NINDS Funding Organization Country United States Related Resources Repository [AlzPED] Pharmacological and Toxicological Properties of the Potent Oral γ-Secretase Modulator BPN-15606.
